PrEP: The Other Blue Pill for Sex Pre-exposure Prophylaxis Truvada
Channel: Thomas Whitfield
Date: 14/05/2018

What is HIV pre-exposure prophylaxis? PrEP? post-exposure prophylaxis? PEP? Does it protect against AIDS? HIV? Is it only for gay men? 

You've seen the ads in magazine, the posters in the subway and on buses, and maybe even a commercial advertising PrEP. But what is it? What's it used for? Who should be taking it? And, where can it even be found? All these questions answered and more in this episode of S#1t They Won't Tell You in Sex Ed. 

The essentials. PrEP is short for Pre-exposure Prophylaxis, a once daily pill used by individuals who are HIV-negative which is highly effective in the prevention of acquiring HIV. It was approved by the USFDA in 2012 and recommended by the CDC in 2014. It's been around for a while but prescriptions are still low.

Curious if you're someone PrEP might be right for? Watch the video above and find out for yourself. Some of the things you've heard about PrEP are true some are lies. Get the answers in just  five minutes.  

S#1T THEY WON'T TELL YOU IN SEX ED
Episode 5: PrEP: The Other Blue Pill for Sex

FIND ME HERE:
INSTAGRAM @ThomasWhitfield84
TWITTER @LarryTheLlama84
Send me your questions about SEX, LOVE, and RELATIONSHIPS to thomastalksabout@gmail.com

Sex, Love, Relationship Advice http://www.ThomasTalksAbout.com

MUSIC:

Theme music used by permission copyright 2016 Rose Wartell 
"The World is Coming to an End" by Typhoid Rosie 
SPOTIFY https://open.spotify.com/artist/4b8bQ5LEfqSfJRRiuQ5p4g
https://typhoidrosie.bandcamp.com

References:

Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine. 2012; 4: 125-151.

Grant, RM. International Association of Providers of AIDS Care; Dissemination of PrEP Innovations; Paris, France. 2015.

Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure
chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of
Medicine. 2010; 363:2587–2599.

Parsons, J. T., Rendina, H. J., Lassiter, J. M., Whitfield, T. H., Starks, T. J., & Grov, C. (2017). Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes, 74(3), 285-292.

Rendina, H. J., Whitfield, T. H., Grov, C., Starks, T. J., & Parsons, J. T. (2017). Distinguishing hypothetical willingness from behavioral intentions to initiate HIV pre-exposure prophylaxis (PrEP): Findings from a large cohort of gay and bisexual men in the US. Social Science & Medicine, 172, 115-123.

Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, et al. No new HIV
infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting.
Clinical Infectious Diseases. 2015; 61:1601–1603.

https://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM312290.pdf

https://www.cdc.gov/hiv/pdf/guidelines/PrEPguidelines2014.pdf